| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Lundquist Kevin Michael | Chief Financial Officer | C/O CAPSOVISION, INC., 18805 COX AVENUE, SUITE 250, SARATOGA | /s/ Tai Vivatvaraphol, Attorney-in-Fact for Kevin Lundquist | 01 Jul 2025 | 0002074701 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | CV | Stock Option (right to buy) | 01 Jul 2025 | Common Stock | 1,387,500 | $0.1700 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | The options vest as to 25% of the shares subject to the option on November 1, 2025 and as to the remaining 75% of the shares in 36 equal monthly installments thereafter through November 1, 2028, subject to continued service to the Issuer on each such date. The options, to the extent then outstanding and unvested, will vest in full upon a change in control of the Issuer. The number of underlying shares of common stock reported in Column 3 and the exercise price reported in Column 4 do not reflect a one-for-3.33 reverse stock split, to be effective immediately prior to the closing to the Issuer's initial public offering. |
Exhibit 24 - Power of Attorney